Advanced search
Publication Cover
Expert Review of Dermatology Volume 6, 2011 - Issue 2
Journal homepage
5
Views
1
CrossRef citations to date
0
Altmetric
Key Paper Evaluation

The evolving role of avotermin in scar prevention

Allison Nauta Hagey Laboratory for Pediatric and Regenerative Medicine, Division of Plastic and Reconstructive Surgery, Department of Surgery, Institute of Stem Cell Biology and Regenerative Medicine, Stanford University School of Medicine, Stanford, CA, USA; Department of Surgery, Georgetown University Hospital, Washington, DC, USA; Hagey Laboratory for Pediatric and Regenerative Medicine, Division of Plastic and Reconstructive Surgery, Department of Surgery, Institute of Stem Cell Biology and Regenerative Medicine, Stanford University School of Medicine, Stanford, CA, USA; Department of Surgery, Georgetown University Hospital, Washington, DC, USA
,
Geoffrey C Gurtner Hagey Laboratory for Pediatric and Regenerative Medicine, Division of Plastic and Reconstructive Surgery, Department of Surgery, Institute of Stem Cell Biology and Regenerative Medicine, Stanford University School of Medicine, Stanford, CA, USA; Hagey Laboratory for Pediatric and Regenerative Medicine, Division of Plastic and Reconstructive Surgery, Department of Surgery, Institute of Stem Cell Biology and Regenerative Medicine, Stanford University School of Medicine, Stanford, CA, USA
&
Michael T Longaker Hagey Laboratory for Pediatric and Regenerative Medicine, Division of Plastic and Reconstructive Surgery, Department of Surgery, Institute of Stem Cell Biology and Regenerative Medicine, Stanford University School of Medicine, Stanford, CA, USA;[email protected]
Pages 149-152 | Published online: 10 Jan 2014

References

  • Singer AJ, Clark RA. Cutaneous wound healing. N. Engl. J. Med.341(10), 738–746 (1999).
  • Ferguson MW, Whitby DJ, Shah M, Armstrong J, Siebert JW, Longaker MT. Scar formation: the spectral nature of fetal and adult wound repair. Plast. Reconstr. Surg.97(4), 854–860 (1996).
  • Shah M, Foreman DM, Ferguson MW. Control of scarring in adult wounds by neutralising antibody to transforming growth factor β. Lancet339(8787), 213–214 (1992).
  • Shah M, Foreman DM, Ferguson MW. Neutralisation of TGF-β1 and TGF-β2 or exogenous addition of TGF-β3 to cutaneous rat wounds reduces scarring. J. Cell Sci.108(Pt 3), 985–1002 (1995).
  • Shah M, Foreman DM, Ferguson MW. Neutralising antibody to TGF-β 1,2 reduces cutaneous scarring in adult rodents. J. Cell Sci.107(Pt 5), 1137–1157 (1994).
  • O’Kane S, Ferguson MW. Transforming growth factor βs and wound healing. Int. J. Biochem. Cell Biol.29(1), 63–78 (1997).
  • Chen W, Fu X, Ge S et al. Ontogeny of expression of transforming growth factor-β and its receptors and their possible relationship with scarless healing in human fetal skin. Wound Repair Regen.13(1), 68–75 (2005).
  • Occleston NL, Laverty HG, O’Kane S, Ferguson MW. Prevention and reduction of scarring in the skin by transforming growth factor β3 (TGFβ3): from laboratory discovery to clinical pharmaceutical. J. Biomater. Sci. Polym. Ed.19(8), 1047–1063 (2008).
  • Bandyopadhyay B, Fan J, Guan S et al. A ‘traffic control’ role for TGFβ3: orchestrating dermal and epidermal cell motility during wound healing. J. Cell Biol.172(7), 1093–1105 (2006).
  • Denhez F, Lafyatis R, Kondaiah P, Roberts AB, Sporn MB. Cloning by polymerase chain reaction of a new mouse TGF-β, mTGF-β3. Growth Factors3(2), 139–146 (1990).
  • Meier K, Nanney LB. Emerging new drugs for scar reduction. Expert Opin. Emerg. Drugs11(1), 39–47 (2006).
  • Bush J, Duncan JA, Bond JS et al. Scar-improving efficacy of avotermin administered into the wound margins of skin incisions as evaluated by a randomized, double-blind, placebo-controlled, Phase II clinical trial. Plast. Reconstr. Surg.126(5), 1604–1615 (2010).
  • Ferguson MW, Duncan J, Bond J et al. Prophylactic administration of avotermin for improvement of skin scarring: three double-blind, placebo-controlled, Phase I/II studies. Lancet373(9671), 1264–1274 (2009).
  • Tyrone JW, Marcus JR, Bonomo SR, Mogford JE, Xia Y, Mustoe TA. Transforming growth factor β3 promotes fascial wound healing in a new animal model. Arch. Surg.135(10), 1154–1159 (2000).
  • Wu L, Siddiqui A, Morris DE, Cox DA, Roth SI, Mustoe TA. Transforming growth factor β3 (TGF β3) accelerates wound healing without alteration of scar prominence. Histologic and competitive reverse-transcription-polymerase chain reaction studies. Arch. Surg.132(7), 753–760 (1997).
  • Durani P, Occleston N, O’Kane S, Ferguson MW. Avotermin: a novel antiscarring agent. Int. J. Low Extrem. Wounds7(3), 160–168 (2008).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.